Keyphrases
Bladder Cancer
100%
Molecular Biology
100%
Cancer Prognostics
100%
Marker Panel
66%
Clinical Trials
33%
Protein Drug
33%
Cancer Management
33%
Molecular Determinants
33%
Molecular Factors
33%
Therapeutic Efficacy
33%
Patient Management
33%
Prognostic Marker
33%
Molecular Markers
33%
Apoptotic Pathway
33%
Clinical Parameters
33%
Treatment Decisions
33%
Diagnostic Marker
33%
Gene Transcript
33%
Technological Progress
33%
Deregulation
33%
Clinical Value
33%
Molecular Profile
33%
Multiple Markers
33%
Urothelial Carcinoma
33%
Cell Cycle Pathway
33%
Single Marker Analysis
33%
Angiogenesis Pathways
33%
Therapeutic Marker
33%
Biochemistry, Genetics and Molecular Biology
Clinical Trial
100%
P53
100%
Angiogenesis
100%
Cell Cycle
100%
Genetic Marker
100%
Molecular Biology
100%
Programmed Cell Death
100%
Pharmacology, Toxicology and Pharmaceutical Science
Bladder Cancer
100%
Combination Therapy
33%
Clinical Trial
33%
Protein P53
33%
Transitional Cell Carcinoma
33%
Apoptosis
33%
Molecular Marker
33%